FDA Drug recall D-0238-2017
Virt-Advance Prenatal/Postnatal Softgels, Prescription Folic Acid Containing Dietary Supplement, packaged in 90-count bottle, Rx only, Made…
- FDA Drug
- Class III
- terminated
- Published 2017-01-04
On 2017-01-04 the FDA classified a Class III recall of Virt-Advance Prenatal/Postnatal Softgels, Prescription Folic Acid Containing Dietary Supplement, packaged in 90-count bottle, Rx only, Made… by Virtus Pharmaceuticals Opco Ii L, citing cGMP Deviations: Active Pharmaceutical Ingredient (API) manufacturer is on FDA Import Alert.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0238-2017 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2016-12-12 |
| Published | 2017-01-04 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Virtus Pharmaceuticals Opco Ii L |
| Distribution | US |
Product
Virt-Advance Prenatal/Postnatal Softgels, Prescription Folic Acid Containing Dietary Supplement, packaged in 90-count bottle, Rx only, Made in Canada, NDC 76439-357-90
Reason
cGMP Deviations: Active Pharmaceutical Ingredient (API) manufacturer is on FDA Import Alert.
Identifiers
| code_info | Lots #: 41505136 Exp. Date 5/30/2017 and 41605134 Exp. date 4/30/2018 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0238-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.